✦ LIBER ✦

Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan's syndrome

✍ Scribed by G. Vaiopoulos; P. P. Sfikakis; B. Skoumas; E. Kavouklis; E. Doukas; Ph. Kaklamanis

Publisher: Springer
Year: 1994
Tongue: English
Weight: 298 KB
Volume: 13
Category: Article
ISSN: 0770-3198
DOI: 10.1007/bf02229876

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous pulse cyclophosphamide thera

Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome

✍ J. P. Leroy; A. A. Drosos; D. I. Yiannopoulos; P. Youinou; H. M. Moutsopoulos 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 1 views

We describe a patient with primary Sjogren's syndrome who developed myositis. The results of muscle pathologic analysis before and after treatment with monthly pulses of cyclophosphamide (intravenously), are presented. Late-onset myositis has been described in patients with Sjogren's syndrome (SS)

Corticosteroids plus pulse cyclophospham

Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and churg-strauss syndrome patients with factors predicting poor prognosis

✍ Loïc Guillevin; François Lhote; Pascal Cohen; Bernard Jarrousse; Olivier Lorthol 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB

Do glutathione-S-transferase polymorphis

Do glutathione-S-transferase polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephrotic syndrome?

✍ Sheetal V. Sharda; Sanjeev Gulati; Gaurav Tripathi; Tabrez Jafar; Alok Kumar; Ra 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 106 KB

Lymphocytic infiltrates as a presenting

Lymphocytic infiltrates as a presenting feature of Sweet's syndrome with myelodysplasia and response to cyclophosphamide

✍ A.V. Evans; R.A. Sabroe; K. Liddell; R. Russell-Jones 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Remission of the Renal Involvement in a

Remission of the Renal Involvement in a Patient with Primary Sjo¨gren’s Syndrome (SS) after Pulse High-Dose Corticosteroid Infusion Therapy

✍ Y. Saeki; S. Ohshima; T. Ishida; Y. Shima; M. Umeshita-Sasai; K. Nishioka; N. Ya 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 197 KB

Cytochrome P450 pharmacogenetics as a pr

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

✍ Kazuki Takada; Million Arefayene; Zeruesenay Desta; Cheryl H. Yarboro; Dimitrios 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## Objective Pulse cyclophosphamide is the treatment of choice for severe lupus nephritis. However, not all patients respond to this therapy, and gonadal toxicity is of particular concern. Cyclophosphamide is a prodrug that requires activation by cytochrome P450 (CYP) enzymes. We condu